News & Information
September 9, 2026
After Moderna's Positive Phase‑3 Readout: The Second Half of the Tumor Vaccine Race, Who Is Unlocking Druggability and Commercialization?
Explore More
June 16, 2026
Minkai Biomedical Joins the "Expert Support for Enterprises · Tour of Yanzhao" Event in Qinhuangdao
Explore More
May 19, 2026
Transforming Cancer into a Manageable Chronic Disease: Professor Wang Zhe, CTO of Minkai Biomedical, Explores How Immunomics Is Reshaping the Future of Cancer Therapy
Explore More
November 26, 2025
The Innovative Cancer Vaccine and Immunotherapy Research Center of Minkai Biomedical has been officially inaugurated in Lisbon, accelerating China–Europe collaboration and strengthening leadership in the cancer peptide vaccine field
Explore More
November 7, 2025
The Rise of Cancer Vaccines: Driving a Breakthrough in Immunotherapy Against Cancer
Explore More
September 25, 2025
A Multi-Billion Dollar Market: Neoantigen Vaccines Pioneering a New Paradigm in Cancer Treatment
Explore More
1 2